Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study

Authors: Amphan Chalermchockcharoenkit, Chenchit Chayachinda, Manopchai Thamkhantho, Chulaluk Komoltri

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Cervical cancer is one of the most common AIDS-related malignancies in Thailand. To prevent cervical cancer, The US Public Health Service and The Infectious Disease Society of America have recommended that all HIV-infected women should obtain 2 Pap smears 6 months apart after the initial HIV diagnosis and, if results of both are normal, should undergo annual cytological screening. However, there has been no evidence in supporting whether this guideline is appropriate in all settings - especially in areas where HIV-infected women are living in resource-constrained condition.

Methods

To determine the appropriate interval of Pap smear screenings for HIV-infected Thai women and risk factors for subsequent abnormal cervical cytology, we assessed the prevalence, cumulative incidence and associated factors of cervical cell abnormalities (atypical squamous cell of undetermined significance or higher grades, ASCUS+) among this group of patients.

Results

The prevalence of ASCUS+ was 15.4% at the first visit, and the cumulative incidence of ASCUS+ gradually increased to 37% in the first 3.5 years of follow-up appointments (first 7 times), and tended to plateau in the last 2 years. For multivariate correlation analysis, women with a CD4 count <350 cells/μL had a significant correlation with ASCUS+ (P = 0.043). There were no associations of subsequent ASCUS+ with age, pregnancy, contraceptive method, highly active anti-retroviral treatment, assumed duration of infection, or the CD4 count nadir level.

Conclusion

There are high prevalence and cumulative incidence of ASCUS+ in HIV-infected Thai women. With a high lost-to-follow-up rate, an appropriate interval of Pap smear screening cannot be concluded from the present study. Nevertheless, the HIV-infected Thai women may require more than two normal semi-annual Pap smears before shifting to routinely annual cytologic screening.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S: Malignancies in HIV-infected Thai patients. HIV Med. 2007, 8 (5): 322-3. 10.1111/j.1468-1293.2007.00471.x.CrossRefPubMed Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S: Malignancies in HIV-infected Thai patients. HIV Med. 2007, 8 (5): 322-3. 10.1111/j.1468-1293.2007.00471.x.CrossRefPubMed
3.
go back to reference Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000, 283 (8): 1031-7. 10.1001/jama.283.8.1031.CrossRefPubMed Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000, 283 (8): 1031-7. 10.1001/jama.283.8.1031.CrossRefPubMed
4.
go back to reference Chalermchockcharoenkit A, Sirimai K, Chaisilwattana P: High prevalence of cervical squamous cell abnormalities among HIV-infected women with immunological AIDS-defining illnesses. J Obstet Gynaecol Res. 2006, 32 (3): 324-9. 10.1111/j.1447-0756.2006.00411.x.CrossRefPubMed Chalermchockcharoenkit A, Sirimai K, Chaisilwattana P: High prevalence of cervical squamous cell abnormalities among HIV-infected women with immunological AIDS-defining illnesses. J Obstet Gynaecol Res. 2006, 32 (3): 324-9. 10.1111/j.1447-0756.2006.00411.x.CrossRefPubMed
5.
go back to reference Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clarke L: Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol. 1999, 180 (4): 824-36. 10.1016/S0002-9378(99)70653-8.CrossRefPubMed Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clarke L: Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol. 1999, 180 (4): 824-36. 10.1016/S0002-9378(99)70653-8.CrossRefPubMed
6.
go back to reference Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol. 1994, 84 (4): 591-7.PubMed Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol. 1994, 84 (4): 591-7.PubMed
7.
go back to reference Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, Minkoff H: Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 1998, 68 (3): 233-9. 10.1006/gyno.1998.4938.CrossRefPubMed Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, Minkoff H: Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 1998, 68 (3): 233-9. 10.1006/gyno.1998.4938.CrossRefPubMed
8.
go back to reference Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Buren D, Greenblatt RM, Muderspach LI, Miotti P: Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr. 1999, 21 (1): 33-41.CrossRefPubMed Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Buren D, Greenblatt RM, Muderspach LI, Miotti P: Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr. 1999, 21 (1): 33-41.CrossRefPubMed
9.
go back to reference Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA: Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002, 288 (14): 1749-57. 10.1001/jama.288.14.1749.CrossRefPubMed Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA: Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002, 288 (14): 1749-57. 10.1001/jama.288.14.1749.CrossRefPubMed
10.
go back to reference Ratnam S, Franco EL, Ferenczy A: Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 945-51.PubMed Ratnam S, Franco EL, Ferenczy A: Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 945-51.PubMed
11.
go back to reference Schneider A, Hoyer H, Lotz B, Leistritza S, Kuhne-Heid R, Nindl I, Muller B, Haerting J, Durst M: Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000, 89 (6): 529-34. 10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G.CrossRefPubMed Schneider A, Hoyer H, Lotz B, Leistritza S, Kuhne-Heid R, Nindl I, Muller B, Haerting J, Durst M: Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000, 89 (6): 529-34. 10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G.CrossRefPubMed
12.
go back to reference Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000, 132 (10): 810-9.CrossRefPubMed Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000, 132 (10): 810-9.CrossRefPubMed
13.
go back to reference CDC: Guidelines for preventing opportunistic infections among HIV-infected persons-2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Socciety of America. WWMR Recomm Rep. 2002, 5 (RR-8): 1-52. CDC: Guidelines for preventing opportunistic infections among HIV-infected persons-2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Socciety of America. WWMR Recomm Rep. 2002, 5 (RR-8): 1-52.
14.
go back to reference Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Shueman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002, 287 (16): 2114-9. 10.1001/jama.287.16.2114.CrossRefPubMed Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Shueman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002, 287 (16): 2114-9. 10.1001/jama.287.16.2114.CrossRefPubMed
15.
go back to reference Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002, 287 (16): 2120-9. 10.1001/jama.287.16.2120.CrossRefPubMed Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002, 287 (16): 2120-9. 10.1001/jama.287.16.2120.CrossRefPubMed
16.
go back to reference Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A: Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis. 2006, 42 (4): 562-8. 10.1086/499357.CrossRefPubMed Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A: Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis. 2006, 42 (4): 562-8. 10.1086/499357.CrossRefPubMed
17.
go back to reference Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD: Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 2005, 293 (12): 1471-6. 10.1001/jama.293.12.1471.CrossRefPubMed Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD: Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 2005, 293 (12): 1471-6. 10.1001/jama.293.12.1471.CrossRefPubMed
18.
go back to reference Agaba PA, Thacher TD, Ekwempu CC, Idoko JA: Cervical dysplasia in Nigerian women infected with HIV. Int J Gynaecol Obstet. 2009, 107 (2): 99-102. 10.1016/j.ijgo.2009.06.006.CrossRefPubMed Agaba PA, Thacher TD, Ekwempu CC, Idoko JA: Cervical dysplasia in Nigerian women infected with HIV. Int J Gynaecol Obstet. 2009, 107 (2): 99-102. 10.1016/j.ijgo.2009.06.006.CrossRefPubMed
19.
go back to reference Micheletti AM, Dutra Vde F, Murta EF, Paschoini MC, Silva-Vergara ML, Barbosa e Silva G, Adad SJ: Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load. Diagn Cytopathol. 2009, 37 (3): 164-9. 10.1002/dc.20892.CrossRefPubMed Micheletti AM, Dutra Vde F, Murta EF, Paschoini MC, Silva-Vergara ML, Barbosa e Silva G, Adad SJ: Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load. Diagn Cytopathol. 2009, 37 (3): 164-9. 10.1002/dc.20892.CrossRefPubMed
20.
go back to reference Franceschi S, Dal Maso L, Suligoi B, Rezza G: Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev. 2006, 15 (6): 554-6. 10.1097/01.cej.0000220640.69341.59.CrossRefPubMed Franceschi S, Dal Maso L, Suligoi B, Rezza G: Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev. 2006, 15 (6): 554-6. 10.1097/01.cej.0000220640.69341.59.CrossRefPubMed
21.
go back to reference Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Virapat P, Tunthanathip P, Ausavapipit J, Lokpichat S, Siangphoe U, Jirarojwat N, Pobkeeree V, Supawitkul S, Tappero JW, Levine WC: Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project. Sex Transm Dis. 2007, 34 (2): 104-7. 10.1097/01.olq.0000222716.17186.9f.CrossRefPubMed Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Virapat P, Tunthanathip P, Ausavapipit J, Lokpichat S, Siangphoe U, Jirarojwat N, Pobkeeree V, Supawitkul S, Tappero JW, Levine WC: Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project. Sex Transm Dis. 2007, 34 (2): 104-7. 10.1097/01.olq.0000222716.17186.9f.CrossRefPubMed
22.
go back to reference De Vuyst H, Lillo F, Broutet N, Smith JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008, 17 (6): 545-54. 10.1097/CEJ.0b013e3282f75ea1.CrossRefPubMed De Vuyst H, Lillo F, Broutet N, Smith JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008, 17 (6): 545-54. 10.1097/CEJ.0b013e3282f75ea1.CrossRefPubMed
23.
go back to reference Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ: Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Journal of the National Cancer Institute. 2004, 96 (14): 1070-6. 10.1093/jnci/djh192.CrossRefPubMed Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ: Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Journal of the National Cancer Institute. 2004, 96 (14): 1070-6. 10.1093/jnci/djh192.CrossRefPubMed
24.
go back to reference Levi JE, Fink MC, Canto CL, Carretiero N, Matsubara R, Linhares I, Das Dores GB, Castelo A, Segurado A, Uip DE, Eluf JJ: Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis. 2002, 6 (3): 129-35. 10.1590/S1413-86702002000300005.CrossRefPubMed Levi JE, Fink MC, Canto CL, Carretiero N, Matsubara R, Linhares I, Das Dores GB, Castelo A, Segurado A, Uip DE, Eluf JJ: Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Braz J Infect Dis. 2002, 6 (3): 129-35. 10.1590/S1413-86702002000300005.CrossRefPubMed
25.
go back to reference Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute. 1999, 91 (3): 226-36. 10.1093/jnci/91.3.226.CrossRefPubMed Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute. 1999, 91 (3): 226-36. 10.1093/jnci/91.3.226.CrossRefPubMed
26.
go back to reference Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, Moore C, Heard I, Agarossi A, Casolati E, Denny L, Bradbeer C, Lyons F, Beattie G, Niemiec T: Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer. 2007, 121 (11): 2484-91. 10.1002/ijc.22947.CrossRefPubMed Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, Moore C, Heard I, Agarossi A, Casolati E, Denny L, Bradbeer C, Lyons F, Beattie G, Niemiec T: Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer. 2007, 121 (11): 2484-91. 10.1002/ijc.22947.CrossRefPubMed
27.
go back to reference Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV: HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 2000, 85 (2): 206-10.CrossRefPubMed Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV: HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 2000, 85 (2): 206-10.CrossRefPubMed
28.
go back to reference Holcomb K, Abulafia O, Matthews RP, Chapman JE, Borges A, Lee YC, Buhl A: The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol. 1999, 75 (1): 118-21. 10.1006/gyno.1999.5554.CrossRefPubMed Holcomb K, Abulafia O, Matthews RP, Chapman JE, Borges A, Lee YC, Buhl A: The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol. 1999, 75 (1): 118-21. 10.1006/gyno.1999.5554.CrossRefPubMed
29.
go back to reference Frazer IH: Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004, 4 (1): 46-54. 10.1038/nri1260.CrossRefPubMed Frazer IH: Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004, 4 (1): 46-54. 10.1038/nri1260.CrossRefPubMed
Metadata
Title
Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study
Authors
Amphan Chalermchockcharoenkit
Chenchit Chayachinda
Manopchai Thamkhantho
Chulaluk Komoltri
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-8

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue